Hepatocellular carcinoma: Understanding molecular mechanisms for defining potential clinical modalities.

Natu, Abhiram; Singh, Anjali; Gupta, Sanjay

Natu, Abhiram; Singh, Anjali; Gupta, Sanjay.

Afiliación

Natu A; Epigenetics and Chromatin Biology Group, Gupta Laboratory, Cancer Research Institute, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Kharghar, Navi Mumbai 410210, Maharashtra, India.
Singh A; Epigenetics and Chromatin Biology Group, Gupta Laboratory, Cancer Research Institute, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Kharghar, Navi Mumbai 410210, Maharashtra, India.
Gupta S; Epigenetics and Chromatin Biology Group, Gupta Laboratory, Cancer Research Institute, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Kharghar, Navi Mumbai 410210, Maharashtra, India.

World J Hepatol ; 13(11): 1568-1583, 2021 Nov 27.

Article en En | MEDLINE | ID: mdl-34904030

Palabras clave

Diagnosis; Drug resistance; Epi-drugs; Epigenetics; Hepatocellular carcinoma; Treatment

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: World J Hepatol Año: 2021 Tipo del documento: Article País de afiliación: India Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google